BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen H, Zhang D, Wang S, Wang X, Yang C. Significance of correlation between interferon-γ and soluble intercellular adhesion molecule-1 and interleukin-17 in hepatitis B virus-related cirrhosis. Clin Res Hepatol Gastroenterol. 2013;37:608-613. [PMID: 23796976 DOI: 10.1016/j.clinre.2013.05.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Wu W, Zeng Y, Lin J, Chen T, Xun Z, Li B, Wang C, Qin X, Qiu Y, Li Y, Chen M, Liang H, Li L, Shang H, Liu C, Ou Q. IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population. Infect Genet Evol 2021;87:104638. [PMID: 33232805 DOI: 10.1016/j.meegid.2020.104638] [Reference Citation Analysis]
2 Cheng L, Geng L, Dai B, Zheng T, Fu J, Qiao L, Cai W, Wang Y, Yang J. Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation. Cell Death Dis 2018;9:489. [PMID: 29695839 DOI: 10.1038/s41419-018-0477-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
3 Asuri S, Mcintosh S, Taylor V, Rokeby A, Kelly J, Shumansky K, Field LL, Yoshida EM, Arbour L. Primary Biliary Cholangitis in British Columbia First Nations: Clinical features and discovery of novel genetic susceptibility loci. Liver Int 2018;38:940-8. [DOI: 10.1111/liv.13686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
4 Bao S, Zheng J, Shi G. The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review). Mol Med Rep 2017;16:3713-9. [PMID: 28731149 DOI: 10.3892/mmr.2017.7044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 程笑, 汪莉萍, 韩方正, 庞亚博, 黄姜伟. 聚乙二醇干扰素α-2a对慢性乙型肝炎患者外周血单个核细胞表面IFNGR1的影响. 世界华人消化杂志 2017; 25(19): 1743-1749 [DOI: 10.11569/wcjd.v25.i19.1743] [Reference Citation Analysis]
6 Wang B, Liu J, Xiong Y, Yan Y, Sun B, Zhao Q, Duan L, Li P, Huang Y, Chen W. Soluble E-cadherin as a serum biomarker in patients with HBV-related liver diseases. Clinical Biochemistry 2016;49:1232-7. [DOI: 10.1016/j.clinbiochem.2016.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Dirchwolf M, Podhorzer A, Marino M, Shulman C, Cartier M, Zunino M, Paz S, Muñoz A, Bocassi A, Gimenez J, Di Pietro L, Romero G, Fainboim H, Fainboim L. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity. Cytokine 2016;77:14-25. [DOI: 10.1016/j.cyto.2015.10.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
8 Wang J, Liu Y, Xie L, Li S, Qin X. Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study. Clin Res Hepatol Gastroenterol 2016;40:288-96. [PMID: 26546176 DOI: 10.1016/j.clinre.2015.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 He WM, Su Y. Progress in research of IL-10 and IL-17 in chronic hepatitis B, hepatitis B virus-related liver cirrhosis and cirrhosis with abdominal infection. Shijie Huaren Xiaohua Zazhi 2014; 22(3): 333-339 [DOI: 10.11569/wcjd.v22.i3.333] [Reference Citation Analysis]